Liquid biopsy during brain tumor surgery with 5-ALA
Part of Cancer clinical trials.
This trial is studying whether a 'liquid biopsy' (a blood test) can help guide brain tumor surgery. It uses a special dye called 5-ALA to help surgeons see the tumor during surgery, and researchers will look for tumor DNA in the blood to see if it matches what is found in the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain tumor (either a glioblastoma that is being treated for the first time, or another type of brain tumor).
- You are able to give your consent to participate.
- You are eligible for brain surgery using a special dye called 5-ALA (which helps the surgeon see the tumor better).
- You do not have any other active cancer in your body.
- You do not have severe kidney disease, are not allergic to MRI contrast dye, and do not have metal implants that prevent MRI scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
This trial tests a new way to take a tiny tissue sample from a suspected glioblastoma using ultrasound, to improve noninvasive detection. You may be able to get this targeted sample while you’re already planning surgery for tumor removal.
This study tests a special imaging device used during brain tumor removal surgery. The device uses a fluorescent dye to help the surgeon see high-grade glioma (a type of brain tumor) more clearly. It aims to collect data on the device's performance and safety.
This trial tests a new approach that uses a light-sensitive drug and low-intensity ultrasound to make standard chemotherapy more effective for glioblastoma. If you have completed initial treatment with radiation and temozolomide without the tumor growing, you may be eligible.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.